AstraZeneca investors raise concerns over mega-merger talks

1 month ago 32

Want Your Business Featured Here?

Get instant exposure to our readers

Chat on WhatsApp

Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb

Read Entire Article